BioPharmSignal logoBioPharmSignal

Biotech News

electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub

electroCore (ECOR)electroCoreCommercial

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Toronto 2026 Powered by MicroCapClub being held at the Arcadian Court & Loft . Joshua Lev, Co-CEO, President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.

Related news

ECORelectroCore2026-09-10 12:00 EST

electroCore to Participate at H.C. Wainwright Global Investment Conference

ECORelectroCore2026-09-09 12:00 EST

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

XERSXeris Pharmaceuticals2026-10-15 12:00 EST

Xeris Biopharma Reinforces Leadership in Endocrinology With Data Disclosures Spanning Commercial Portfolio and Pipeline at Multiple Scientific Meetings

TNXPTonix Pharmaceuticals2026-10-15 11:00 EST

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026

SNYSanofi2026-10-12 16:05 EST

Sanofi: Information concerning the total number of voting rights and shares – September 2026

TNXPTonix Pharmaceuticals2026-09-22 11:00 EST

Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®

ALKSAlkermes plc2026-09-10 11:00 EST

Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program

ABOSAcumen Pharmaceuticals2026-10-22 11:30 EST

Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

CLNNClene Inc.2026-09-22 12:00 EST

Clene to Present at Upcoming Investor Conferences

CLNNClene Inc.2026-09-03 12:00 EST

Clene to Present at Upcoming September Investor Conferences

View all latest news

electroCore

Noninvasive Neuromodulation electroCore develops handheld bioelectronic devices that stimulate the vagus nerve without surgery. Its products are used across prescription and consumer channels. gammaCore gammaCore is a prescription noninvasive vagus-nerve-stimulation device used for headache disorders. A major commercial channel is the...

Recent company news

ECORelectroCore2026-10-21 12:00 EST

electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub

ECORelectroCore2026-09-10 12:00 EST

electroCore to Participate at H.C. Wainwright Global Investment Conference

ECORelectroCore2026-09-09 12:00 EST

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

ECORelectroCore2026-08-25 12:00 EST

electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

ECORelectroCore2026-08-06 20:05 EST

electroCore Announces Second Quarter 2026 Financial Results

Stock data

Close
7.41 USD
Market cap
78.39M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States